Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms.
Int J Geriatr Psychiatry. 2008.
PMID: 17582225
Clinical Trial.
Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 0 |
Search Results
19 results
Results by year
Citations
1
article
found by citation matching
Search results
Page 1
Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms.
Int J Geriatr Psychiatry. 2008 Feb;23(2):161-9. doi: 10.1002/gps.1857.
Int J Geriatr Psychiatry. 2008.
PMID: 17582225
Clinical Trial.
BACKGROUND: Epidemiological and animal studies have suggested that dietary fish or fish oil rich in omega-3 fatty acids (omega3), docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), may have effects in psychiatric and behavioral symptoms in …
BACKGROUND: Epidemiological and animal studies have suggested that dietary fish or fish oil rich in omega-3 fatty ac …
Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer's Disease: The OmegAD Study.
J Alzheimers Dis. 2019;69(1):189-197. doi: 10.3233/JAD-181148.
J Alzheimers Dis. 2019.
PMID: 30958356
Clinical Trial.
BACKGROUND: Trials of supplementation with omega-3 fatty acids (omega3-FAs) in patients with mild cognitive impairment or Alzheimer's disease (AD) have produced inconsistent effects on cognitive decline. ...OBJECTIVE: …
BACKGROUND: Trials of supplementation with omega-3 fatty acids (omega3-FAs) in patients with mild …
Effect of nutrition in Alzheimer's disease: A systematic review.
Front Neurosci. 2023 May 4;17:1147177. doi: 10.3389/fnins.2023.1147177. eCollection 2023.
Front Neurosci. 2023.
PMID: 37214392
Free PMC article.
BACKGROUND AND OBJECTIVE: Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by declining cognitive ability. ...In contrast, the Mediterranean diet, ketogenic diet, and supplementation with omega-3 …
BACKGROUND AND OBJECTIVE: Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by d …
Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
Arch Neurol. 2006 Oct;63(10):1402-8. doi: 10.1001/archneur.63.10.1402.
Arch Neurol. 2006.
PMID: 17030655
Clinical Trial.
BACKGROUND: Epidemiologic and animal studies have suggested that dietary fish or fish oil rich in omega-3 fatty acids, for example, docosahexaenoic acid and eicosapentaenoic acid, may prevent Alzheimer disease (AD). OBJECTIVE: To determin …
BACKGROUND: Epidemiologic and animal studies have suggested that dietary fish or fish oil rich in omega-3 fatty acid …
Plasma Fatty Acid Profiles in Relation to Cognition and Gender in Alzheimer's Disease Patients During Oral Omega-3 Fatty Acid Supplementation: The OmegAD Study.
J Alzheimers Dis. 2015;48(3):805-12. doi: 10.3233/JAD-150102.
J Alzheimers Dis. 2015.
PMID: 26402079
Clinical Trial.
BACKGROUND: omega3 fatty acids (omega3 FAs) may slow the rate of decline in cognitive performance in mild forms of cognitive impairment and Alzheimer's disease (AD). ...OBJECTIVE: To study the effect of 6-month administration of DHA-rich …
BACKGROUND: omega3 fatty acids (omega3 FAs) may slow the rate of decline in cognitive performance in mild forms of cogn …
Dietary and supplemental long-chain omega-3 fatty acids as moderators of cognitive impairment and Alzheimer's disease.
Eur J Nutr. 2022 Mar;61(2):589-604. doi: 10.1007/s00394-021-02655-4. Epub 2021 Aug 15.
Eur J Nutr. 2022.
PMID: 34392394
Free PMC article.
Review.
METHODS: Studies were identified in PubMed and Scopus using the search terms "omega-3 fatty acids", "Alzheimer's disease" and "cognition", along with common variants. ...The protective effects LC omega3 PUFAs on cognitive function …
METHODS: Studies were identified in PubMed and Scopus using the search terms "omega-3 fatty acids", "Alzheime …
Mitochondrial Pharmaceutics: A New Therapeutic Strategy to Ameliorate Oxidative Stress in Alzheimer's Disease.
Curr Aging Sci. 2015;8(3):235-40. doi: 10.2174/187460980803151027115147.
Curr Aging Sci. 2015.
PMID: 25986626
Review.
Association between amyloid-beta (Abeta) toxicity, mitochondrial dysfunction, oxidative stress and neuronal damage has been demonstrated in the pathophysiology of Alzheimer's disease (AD). In the early stages of the disease, the defect in energy metabo …
Association between amyloid-beta (Abeta) toxicity, mitochondrial dysfunction, oxidative stress and neuronal damage has been demonstrated in …
Fish consumption and omega-3 fatty acid supplementation for prevention or treatment of cognitive decline, dementia or Alzheimer's disease in older adults - any news?
Curr Opin Clin Nutr Metab Care. 2017 Mar;20(2):104-109. doi: 10.1097/MCO.0000000000000350.
Curr Opin Clin Nutr Metab Care. 2017.
PMID: 27977429
Review.
PURPOSE OF REVIEW: Twenty years of research indicates that fish and n-3 fatty acids (FAs), for example docosahexaenoic acid, may attenuate cognitive decline including Alzheimer's disease in older people. ...Still, a Cochrane review (using three …
PURPOSE OF REVIEW: Twenty years of research indicates that fish and n-3 fatty acids (FAs), for example docosahexaenoic acid, m …
Treatment of Alzheimer disease.
Am Fam Physician. 2011 Jun 15;83(12):1403-12.
Am Fam Physician. 2011.
PMID: 21671540
Free article.
Alzheimer disease is the most common form of dementia, affecting nearly one-half [corrected] of Americans older than 85 years. ...Amyloid plaque accumulation, neurofibrillary tau tangles, and depletion of acetylcholine are among the pathologic manifestations of A …
Alzheimer disease is the most common form of dementia, affecting nearly one-half [corrected] of Americans older than 85 years. …
The effects of long-term omega-3 fatty acid supplementation on cognition and Alzheimer's pathology in animal models of Alzheimer's disease: a systematic review and meta-analysis.
J Alzheimers Dis. 2012;28(1):191-209. doi: 10.3233/JAD-2011-111217.
J Alzheimers Dis. 2012.
PMID: 22002791
Free article.
To date, only a few randomized clinical trials (RCTs) have investigated the effects of omega-3 fatty acids (FA) on Alzheimer's disease (AD). Some of these studies demonstrated that patients with very mild AD or mild c …
To date, only a few randomized clinical trials (RCTs) have investigated the effects of omega-3 fatty acids (FA) …
Cite